Queen’s University and Kingston, Frontenac and Lennox and Addington (KFL&A) Public Health are leading the collaborative study entitled Syphilis Point-of-care Rapid testing and Immediate Treatment ...
The firm said it will develop a test for use at home and at the point of care to aid the diagnosis of syphilis and distinguish between active and past infections.
Biosynex SA (FR:ALBIO) has released an update. Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop a rapid ...
A new study being presented at this year’s ACAAI Annual Scientific Meeting in Boston showed that syphilis patients labeled as penicillin allergic who are low risk should be delabeled to avoid ...